Acute Myocardial Infarction Global Market Report 2025

Description

Acute myocardial infarction (MI), commonly known as a heart attack, occurs when there is a sudden reduction or complete cessation of blood flow to one or more coronary arteries, resulting in the death of heart muscle tissue. This is typically caused by the rupture of atherosclerotic plaques, leading to a blockage in the blood flow.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of myocardial infarction are ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). STEMI is a more severe form of heart attack, characterized by a complete blockage of a coronary artery, significantly reducing blood flow to the heart muscle. Treatment for acute myocardial infarction involves thrombolytic therapy, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and medications. Diagnosis is performed using various methods, including electrocardiograms (ECG), cardiac biomarkers, echocardiography, coronary angiography, MRI, and CT scans. Medications are administered through different routes, including oral, intravenous (IV), subcutaneous, transdermal, and sublingual. The primary end users for these treatments include hospitals, clinics, ambulatory surgical centers, specialty cardiac centers, and research institutes.

The acute myocardial infarction market research report is one of a series of new reports from The Business Research Company that provides acute myocardial infarction market statistics, including acute myocardial infarction industry global market size, regional shares, competitors with an acute myocardial infarction market share, detailed acute myocardial infarction market segments, market trends and opportunities, and any further data you may need to thrive in the acute myocardial infarction industry. This acute myocardial infarction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute myocardial infarction market size has grown strongly in recent years. It will grow from$1.47 billion in 2024 to $1.56 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth observed during the historical period can be linked to a rise in heart diseases associated with smoking, a higher prevalence of hypertension, advancements in emergency medical services, increased awareness of heart disease risk factors, and the early use of aspirin in cardiovascular treatment.

The acute myocardial infarction market size is expected to see strong growth in the next few years. It will grow to$1.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth projected for the forecast period can be attributed to the growing demand for minimally invasive cardiac procedures, increased investment in regenerative medicine for heart repair, the rising prevalence of obesity and diabetes, and an expanding focus on personalized medicine for heart disease. Key trends during this period include AI-driven early detection systems, wearable ECG monitoring devices, nanotechnology-based drug delivery, 3D bioprinting of cardiac tissues, and advanced robotic-assisted cardiac surgeries.

The rising prevalence of hypertension is expected to significantly drive the growth of the acute myocardial infarction (AMI) market. Hypertension, characterized by persistently high blood pressure, is a major risk factor for heart disease, stroke, and other cardiovascular complications. The increase in hypertension cases can be attributed to modern lifestyle factors, such as sedentary behavior from desk jobs, excessive screen time, and minimal physical activity. Hypertension damages the arteries, promotes plaque buildup, and increases the risk of blood clots, all of which can contribute to acute myocardial infarction. For example, according to a report by the Australian Bureau of Statistics, the prevalence of hypertension in Australia reached 11.6% (approximately 3.0 million people) in 2022. As hypertension rates rise, the growth of the acute myocardial infarction market is anticipated to follow suit.

Key players in the acute myocardial infarction market are increasingly focusing on obtaining regulatory approvals to enhance their product offerings and improve treatment outcomes. Regulatory approvals from agencies such as the FDA and EMA are vital in ensuring that drugs and medical devices meet required safety, efficacy, and quality standards. For instance, in March 2025, Sungen Biomedical, a China-based biopharmaceutical company, received FDA Fast Track Designation for its monoclonal antibody drug, SGC001. This drug, the first of its kind for the emergency treatment of acute myocardial infarction, has shown promising preclinical results in reducing cardiomyocyte apoptosis and improving blood flow in ischemic areas. The Fast Track status allows Sungen Biomedical to fast-track the approval process, enabling quicker access to this potentially life-saving therapy for AMI patients.

In February 2023, BioCardia Inc., a U.S.-based biotechnology company, extended its partnership with CellProthera to advance the development of ProtheraCytes for treating acute myocardial infarction. BioCardia plans to leverage its Helix transendocardial biotherapeutic delivery system for CellProthera's Phase I/IIb EXCELLENT study, focused on its lead product candidate, ProtheraCytes. CellProthera, a France-based company, specializes in regenerative therapies for AMI, and this partnership aims to develop innovative treatments that could significantly improve heart attack recovery outcomes.

Major players in the acute myocardial infarction market are Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Boston Scientific Corporation, Daiichi Sankyo Company Limited, Terumo Corporation, MicroPort Scientific Corporation, Ionis Pharmaceuticals Inc., CellProthera, Athersys Inc., BioCardia Inc., and Serca Pharmaceuticals.

North America was the largest region in the acute myocardial infarction market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acute myocardial infarction report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute myocardial infarction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute myocardial infarction market consists of revenues earned by entities by providing services such as diagnostic testing, telemedicine consultations, remote patient monitoring, pharmaceutical treatments, and post-acute myocardial infarction (AMI) management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute myocardial infarction market also includes sales of pharmaceutical drugs, medical devices, diagnostic tools, wearable cardiac monitors, and telemedicine platforms for remote cardiac care. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Myocardial Infarction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute myocardial infarction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute myocardial infarction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute myocardial infarction market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: ST-Elevation Myocardial Infarction (STEMI); Non-ST-Elevation Myocardial Infarction (NSTEMI)
2) By Treatment Type: Thrombolytic Therapy; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG); Medications
3) By Diagnosis Method: Electrocardiogram; Cardiac Biomarkers; Echocardiography; Coronary Angiography; Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan
4) By Route Of Administration: Oral Route; Intravenous (IV) Route; Subcutaneous Route; Transdermal Route; Sublingual Route
5) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Specialty Cardiac Centers; Research Institutes
Subsegments:
1) ST-Elevation Myocardial Infarction (STEMI): Anterior ST-Elevation Myocardial Infarction (STEMI); Inferior ST-Elevation Myocardial Infarction (STEMI); Posterior ST-Elevation Myocardial Infarction (STEMI); Lateral ST-Elevation Myocardial Infarction (STEMI); Right Ventricular ST-Elevation Myocardial Infarction (STEMI); Extensive (Large) ST-Elevation Myocardial Infarction (STEMI)
2) Non-ST-Elevation Myocardial Infarction (NSTEMI): Subendocardial Non-ST-Elevation Myocardial Infarction (NSTEMI); Partial Thickness Non-ST-Elevation Myocardial Infarction (NSTEMI); Multi-Vessel Non-ST-Elevation Myocardial Infarction (NSTEMI); Silent Non-ST-Elevation Myocardial Infarction (NSTEMI); Recurrent Non-ST-Elevation Myocardial Infarction (NSTEMI)
Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34743

1. Executive Summary

2. Acute Myocardial Infarction Market Characteristics

3. Acute Myocardial Infarction Market Trends And Strategies

4. Acute Myocardial Infarction Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Acute Myocardial Infarction Growth Analysis And Strategic Analysis Framework

5.1. Global Acute Myocardial Infarction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Acute Myocardial Infarction Market Growth Rate Analysis
5.4. Global Acute Myocardial Infarction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Acute Myocardial Infarction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Acute Myocardial Infarction Total Addressable Market (TAM)

6. Acute Myocardial Infarction Market Segmentation

6.1. Global Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
ST-Elevation Myocardial Infarction (STEMI)
Non-ST-Elevation Myocardial Infarction (NSTEMI)
6.2. Global Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thrombolytic Therapy
Percutaneous Coronary Intervention (PCI)
Coronary Artery Bypass Grafting (CABG)
Medications
6.3. Global Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electrocardiogram
Cardiac Biomarkers
Echocardiography
Coronary Angiography
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scan
6.4. Global Acute Myocardial Infarction Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Route
Intravenous (IV) Route
Subcutaneous Route
Transdermal Route
Sublingual Route
6.5. Global Acute Myocardial Infarction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgical Centers
Specialty Cardiac Centers
Research Institutes
6.6. Global Acute Myocardial Infarction Market, Sub-Segmentation Of ST-Elevation Myocardial Infarction (STEMI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anterior ST-Elevation Myocardial Infarction (STEMI)
Inferior ST-Elevation Myocardial Infarction (STEMI)
Posterior ST-Elevation Myocardial Infarction (STEMI)
Lateral ST-Elevation Myocardial Infarction (STEMI)
Right Ventricular ST-Elevation Myocardial Infarction (STEMI)
Extensive (Large) ST-Elevation Myocardial Infarction (STEMI)
6.7. Global Acute Myocardial Infarction Market, Sub-Segmentation Of Non-ST-Elevation Myocardial Infarction (NSTEMI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subendocardial Non-ST-Elevation Myocardial Infarction (NSTEMI)
Partial Thickness Non-ST-Elevation Myocardial Infarction (NSTEMI)
Multi-Vessel Non-ST-Elevation Myocardial Infarction (NSTEMI)
Silent Non-ST-Elevation Myocardial Infarction (NSTEMI)
Recurrent Non-ST-Elevation Myocardial Infarction (NSTEMI)

7. Acute Myocardial Infarction Market Regional And Country Analysis

7.1. Global Acute Myocardial Infarction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Acute Myocardial Infarction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Myocardial Infarction Market

8.1. Asia-Pacific Acute Myocardial Infarction Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Myocardial Infarction Market

9.1. China Acute Myocardial Infarction Market Overview
9.2. China Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Myocardial Infarction Market

10.1. India Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Myocardial Infarction Market

11.1. Japan Acute Myocardial Infarction Market Overview
11.2. Japan Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Myocardial Infarction Market

12.1. Australia Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Myocardial Infarction Market

13.1. Indonesia Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Myocardial Infarction Market

14.1. South Korea Acute Myocardial Infarction Market Overview
14.2. South Korea Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Myocardial Infarction Market

15.1. Western Europe Acute Myocardial Infarction Market Overview
15.2. Western Europe Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Myocardial Infarction Market

16.1. UK Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Myocardial Infarction Market

17.1. Germany Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Myocardial Infarction Market

18.1. France Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Myocardial Infarction Market

19.1. Italy Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Myocardial Infarction Market

20.1. Spain Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Myocardial Infarction Market

21.1. Eastern Europe Acute Myocardial Infarction Market Overview
21.2. Eastern Europe Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Myocardial Infarction Market

22.1. Russia Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Myocardial Infarction Market

23.1. North America Acute Myocardial Infarction Market Overview
23.2. North America Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Myocardial Infarction Market

24.1. USA Acute Myocardial Infarction Market Overview
24.2. USA Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Myocardial Infarction Market

25.1. Canada Acute Myocardial Infarction Market Overview
25.2. Canada Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Myocardial Infarction Market

26.1. South America Acute Myocardial Infarction Market Overview
26.2. South America Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Myocardial Infarction Market

27.1. Brazil Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Myocardial Infarction Market

28.1. Middle East Acute Myocardial Infarction Market Overview
28.2. Middle East Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Myocardial Infarction Market

29.1. Africa Acute Myocardial Infarction Market Overview
29.2. Africa Acute Myocardial Infarction Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Acute Myocardial Infarction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Acute Myocardial Infarction Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Myocardial Infarction Market Competitive Landscape And Company Profiles

30.1. Acute Myocardial Infarction Market Competitive Landscape
30.2. Acute Myocardial Infarction Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Acute Myocardial Infarction Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca plc
31.3. Abbott Laboratories
31.4. Novartis AG
31.5. GSK plc
31.6. Eli Lilly and Company
31.7. Siemens Healthineers
31.8. Fujifilm Holdings Corporation
31.9. Koninklijke Philips N.V.
31.10. Boston Scientific Corporation
31.11. Daiichi Sankyo Company Limited
31.12. Terumo Corporation
31.13. MicroPort Scientific Corporation
31.14. Ionis Pharmaceuticals Inc.
31.15. CellProthera

32. Global Acute Myocardial Infarction Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Myocardial Infarction Market

34. Recent Developments In The Acute Myocardial Infarction Market

35. Acute Myocardial Infarction Market High Potential Countries, Segments and Strategies

35.1 Acute Myocardial Infarction Market In 2029 - Countries Offering Most New Opportunities
35.2 Acute Myocardial Infarction Market In 2029 - Segments Offering Most New Opportunities
35.3 Acute Myocardial Infarction Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r34743_Acute_Myocardial_Infarction_GMR_2025